Logo image
Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis
Journal article   Open access   Peer reviewed

Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis

Samantha N Jensen, Nicole M Cady, Shailesh K Shahi, Stephanie R Peterson, Arnav Gupta, Katherine N Gibson-Corley and Ashutosh K Mangalam
Science advances, Vol.7(28), eabd4595
07/01/2021
DOI: 10.1126/sciadv.abd4595
PMCID: PMC8270496
PMID: 34244137
url
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270496View
Published (Version of record) Open Access

Abstract

The gut microbiota is a potential environmental factor that influences the development of multiple sclerosis (MS). We and others have demonstrated that patients with MS and healthy individuals have distinct gut microbiomes. However, the pathogenic relevance of these differences remains unclear. Previously, we showed that bacteria that metabolize isoflavones are less abundant in patients with MS, suggesting that isoflavone-metabolizing bacteria might provide protection against MS. Here, using a mouse model of MS, we report that an isoflavone diet provides protection against disease, which is dependent on the presence of isoflavone-metabolizing bacteria and their metabolite equol. Notably, the composition of the gut microbiome in mice fed an isoflavone diet exhibited parallels to healthy human donors, whereas the composition in those fed an isoflavone-free diet exhibited parallels to patients with MS. Collectively, our study provides evidence that dietary-induced gut microbial changes alleviate disease severity and may contribute to MS pathogenesis.

Details

Metrics

Logo image